Clinical Trial Update: Vectron T500 (Broflanilide 50WP) for IRS in Tanzania Tanzania [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Vectron T500 (Broflanilide 50WP) investigating its use for indoor residual spraying against Falciparum malaria in Tanzania.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Vectron T500 (Broflanilide)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria,Falciparum | Phase 3 | Status: UNKNOWN